Douglas M. Lankler - 25 Feb 2026 Form 4 Insider Report for PFIZER INC (PFE)

Role
Executive Vice President
Signature
/s/ Shanice A. Reid, by power of atty, for Douglas M. Lankler
Issuer symbol
PFE
Transactions as of
25 Feb 2026
Net transactions value
+$952,619
Form type
4
Filing time
27 Feb 2026, 18:35:09 UTC
Previous filing
06 Mar 2025
Next filing
05 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LANKLER DOUGLAS M Executive Vice President 66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK /s/ Shanice A. Reid, by power of atty, for Douglas M. Lankler 25 Feb 2026 0001488270

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Options Exercise $4,156,715 +122,907 +77% $33.82 282,186 25 Feb 2026 Direct F1
transaction PFE Common Stock Tax liability $59,544 -2,198 -0.78% $27.09 279,988 25 Feb 2026 Direct F2
transaction PFE Common Stock Tax liability $3,144,552 -116,811 -42% $26.92 163,177 25 Feb 2026 Direct F3, F4
holding PFE Common Stock 2,083 25 Feb 2026 By Rule 16b-3 Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Options Exercise $0 -122,907 -100% $0.000000 0 25 Feb 2026 Common Stock 122,907 $33.82 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.